Oxytocin in the anterior cingulate cortex attenuates neuropathic pain and emotional anxiety by inhibiting presynaptic long-term potentiation

Cell Rep. 2021 Jul 20;36(3):109411. doi: 10.1016/j.celrep.2021.109411.

Abstract

Oxytocin is a well-known neurohypophysial hormone that plays an important role in behavioral anxiety and nociception. Two major forms of long-term potentiation, presynaptic LTP (pre-LTP) and postsynaptic LTP (post-LTP), have been characterized in the anterior cingulate cortex (ACC). Both pre-LTP and post-LTP contribute to chronic-pain-related anxiety and behavioral sensitization. The roles of oxytocin in the ACC have not been studied. Here, we find that microinjections of oxytocin into the ACC attenuate nociceptive responses and anxiety-like behavioral responses in animals with neuropathic pain. Application of oxytocin selectively blocks the maintenance of pre-LTP but not post-LTP. In addition, oxytocin enhances inhibitory transmission and excites ACC interneurons. Similar results are obtained by using selective optical stimulation of oxytocin-containing projecting terminals in the ACC in animals with neuropathic pain. Our results demonstrate that oxytocin acts on central synapses and reduces chronic-pain-induced anxiety by reducing pre-LTP.

Keywords: anterior cingulate cortex; anxiety; inhibitory transmission; long-term potentiation; neuropathic pain; oxytocin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / pharmacology
  • Animals
  • Anti-Anxiety Agents / pharmacology
  • Anxiety / physiopathology*
  • Behavior, Animal / drug effects
  • Calcium / metabolism
  • Chronic Pain / pathology
  • Chronic Pain / physiopathology
  • Emotions* / drug effects
  • Female
  • Gyrus Cinguli / drug effects
  • Gyrus Cinguli / pathology*
  • Gyrus Cinguli / physiopathology
  • Interneurons / drug effects
  • Light
  • Long-Term Potentiation* / drug effects
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Microinjections
  • Nerve Tissue / drug effects
  • Nerve Tissue / pathology
  • Nerve Tissue / physiopathology
  • Neural Inhibition / drug effects
  • Neuralgia / complications
  • Neuralgia / pathology*
  • Neuralgia / physiopathology*
  • Oxytocin / administration & dosage
  • Oxytocin / pharmacology*
  • Paraventricular Hypothalamic Nucleus / drug effects
  • Paraventricular Hypothalamic Nucleus / pathology
  • Paraventricular Hypothalamic Nucleus / physiopathology
  • Presynaptic Terminals / drug effects
  • Presynaptic Terminals / pathology*
  • Receptors, G-Protein-Coupled / metabolism
  • Receptors, GABA-A / metabolism
  • Receptors, Oxytocin / genetics
  • Receptors, Oxytocin / metabolism
  • Signal Transduction / drug effects
  • Synaptic Transmission / drug effects
  • Up-Regulation / drug effects

Substances

  • Analgesics
  • Anti-Anxiety Agents
  • Receptors, G-Protein-Coupled
  • Receptors, GABA-A
  • Receptors, Oxytocin
  • Oxytocin
  • Calcium

Grants and funding